Saab R.; Rodriguez-Galindo C.; Matmati K.; Rehg J.E.; Baumer S.H.; Khoury J.D.; Billups C.; Neale G.; Helton K.J.; Skapek S.X.
(PHILADELPHIA615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA, 2009)
The retinoblastoma (RB) tumor suppressor pathway is likely important in primitive neuroectodermal tumors (PNET) of the brain. In fact, 10percent to 15percent of children born with RB mutations develop brain PNETs, commonly ...